Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yuji Ishida, MD"'
Publikováno v:
HeartRhythm Case Reports, Vol 7, Iss 11, Pp 776-779 (2021)
Externí odkaz:
https://doaj.org/article/103e9365c05e4801b37ef58531acbe62
Autor:
Yuji Ishida, MD, PhD, Shingo Sasaki, MD, PhD, Yuichi Toyama, MD, Kimitaka Nishizaki, MD, PhD, Yoshihiro Shoji, MD, PhD, Takahiko Kinjo, MD, PhD, Taihei Itoh, MD, PhD, Daisuke Horiuchi, MD, PhD, Masaomi Kimura, MD, PhD, Michael R. Gold, MD, PhD, FHRS, Hirofumi Tomita, MD, PhD
Publikováno v:
Heart Rhythm O2, Vol 1, Iss 1, Pp 27-34 (2020)
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is effective in preventing sudden cardiac death. Compared with transvenous ICDs, S-ICDs have a lower rate of inappropriate shocks (IASs) for supraventricular arrhythmias, but
Externí odkaz:
https://doaj.org/article/e93d73297b1744149585ce84fa2d4f62
Autor:
Yuji Ishida, MD, Shingo Sasaki, MD, Hirofumi Tomita, MD, Masaomi Kimura, MD, Shingen Owada, MD, Daisuke Horiuchi, MD, Kenichi Sasaki, MD, Taihei Itoh, MD, Tomohide Endo, MD, Akiko Suzuki, MD, Shunta Tateyama, MD, Takahiko Kinjo, MD, Ken Okumura, FJCC, MD, PhD
Publikováno v:
Journal of Arrhythmia, Vol 30, Iss 6, Pp 509-512 (2014)
In the present report, we describe the case of a 63-year-old man who received an inappropriate implantable cardioverter defibrillator (ICD) shock due to an epileptic seizure. He experienced an acute myocardial infarction 12 months previously, and his
Externí odkaz:
https://doaj.org/article/753b176a2ca2454d99d14591e8d1d797
Autor:
Yuji Ishida, MD, Shingo Sasaki, MD, Takahiko Kinjo, MD, Taihei Itoh, MD, Kenichi Sasaki, MD, Daisuke Horiuchi, MD, Shingen Owada, MD, Masaomi Kimura, MD, Ken Okumura, MD
Publikováno v:
Journal of Arrhythmia, Vol 30, Iss 5, Pp 367-371 (2014)
Background: Cardiac resynchronization therapy (CRT) reduces the mortality rate among patients with advanced heart failure (HF) and a wide QRS complex. Despite such clinical improvement, the clinical features of ventricular tachyarrhythmias (VA) and t
Externí odkaz:
https://doaj.org/article/e0645a9fff80402f82dbdeb8eaee2811
Autor:
Daisuke Horiuchi, MD, Shingo Sasaki, MD, Takahiko Kinjo, MD, Yuji Ishida, MD, Taihei Itoh, MD, Kenichi Sasaki, MD, Shingen Owada, MD, Masaomi Kimura, MD, Ken Okumura, MD
Publikováno v:
Journal of Arrhythmia, Vol 30, Iss 3, Pp 167-172 (2014)
Background: Atrial fibrillation (AF) often occurs in the acute phase of heart failure (AHF), and is usually associated with a rapid ventricular response. No drug with proven efficacy in the treatment of AF in the setting of AHF has been approved in J
Externí odkaz:
https://doaj.org/article/db09b4bb847547da9458f1c80402d932